Genmab A (GMAB) Research & Development: 2018-2021
- Genmab A's Research & Development fell 36.40% to -$100.70 in Q2 2021 from the same period last year, while for Jun 2021 it was -$321.51, marking a year-over-year decrease of 100.00%. This contributed to the annual value of -$364.4 million for FY2020, which is 46.87% down from last year.
- According to the latest figures from Q2 2021, Genmab A's Research & Development is -$100.70, which was down 20.22% from -$83.76 recorded in Q4 2020.
- Genmab A's 5-year Research & Development high stood at $59.7 million for Q2 2019, and its period low was -$37.9 million during Q4 2018.
- For the 3-year period, Genmab A's Research & Development averaged around $11.9 million, with its median value being -$73.82 (2020).
- In the last 5 years, Genmab A's Research & Development soared by 100.00% in 2019 and then crashed by 100.00% in 2020.
- Over the past 4 years, Genmab A's Research & Development (Quarterly) stood at -$37.9 million in 2018, then spiked by 100.00% to -$63.23 in 2019, then plummeted by 32.47% to -$83.76 in 2020, then crashed by 36.40% to -$100.70 in 2021.
- Its last three reported values are -$100.70 in Q2 2021, -$83.76 for Q4 2020, and -$73.82 during Q2 2020.
